Skip to main content
. 2019 Apr 12;21(8):1005–1015. doi: 10.1093/neuonc/noz066

Table 1.

Patient and tumor characteristics

Variables
Sex (n = 133)
 Male 85 (63.9)
 Female 48 (36.1)
Ethnicity (n = 115)
 African 3 (2.6)
 Asian/Pacific Islander 4 (3.5)
 Caucasian 96 (83.5)
 East Indian 2 (1.7)
 Hispanic 8 (7.0)
 Other 2 (1.7)
Age at time of surgery (years) (n = 133) 55.8 ± 16.4
Pain at Diagnosis (n = 126)
 No 11 (8.7)
 Yes 115 (91.3)
Pathologic Fracture at Diagnosis (n = 126)
 No 117 (92.9)
 Yes 9 (7.1)
Previous Spine Tumor Operation (n = 133)
 No 118 (88.7)
 Yes 15 (11.3)
  Intralesional 10 (66.7)
  Marginal 0 (0.0)
  Wide 1 (6.7)
  Unknown 4 (26.7)
How the Diagnosis Was Performed (n = 123)
 Open biopsy 17 (13.8)
 CT-trocar biopsy 72 (58.5)
 Intraoperative biopsy 21 (17.1)
 Other 13 (10.6)
Spinal Level (n = 132)
 Mobile 47 (35.6)
 Fixed 85 (64.4)
Diagnosis (n = 133)
 Chordoma 92 (69.2)
 Chondrosarcoma 26 (19.5)
 Ewing’s sarcoma 3 (2.3)
 Osteosarcoma 7 (5.3)
 Other malignant soft tissue tumors 5 (3.8)
Tumor Grade (n = 133)
 Low (Ia/Ib) 83 (62.4)
 High (IIa/IIb) 50 (37.6)
TERT Promoter Mutation (n = 133)
 No 121 (91.0)
 Yes 12 (9.0)
TERT Status (n = 133)
 Wildtype 121 (91.0)
 C228T 11 (8.3)
 C250T 1 (0.7)

Data are presented as N (%), mean ± standard deviation or median (p25, p75).